Highly complex chromosomal aberrations in bone marrow of a patient with metastatic prostate neoplasm

Cancer Genetics and Cytogenetics

Volumn 99, Issue 2, 1997, Pages 116-120

  Azar, Georgia M ^a   Dipillo, Frank ^a   Gogineni, Swarna K ^a   Godec, Ciril J ^a   Verma, Ram S ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CARCINOGENESIS; CASE REPORT; CHROMOSOME 1; CHROMOSOME 10Q; CHROMOSOME 12P; CHROMOSOME 17Q; CHROMOSOME 7Q; CHROMOSOME 8P; CLINICAL FEATURE; HUMAN; LOW BACK PAIN; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TREATMENT PLANNING;

EID: 0030732703     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00199-4     Document Type: Article

References (36)

1. Denis LJ, Murphy GP, Schröder FH Report of the Consensus Workshop on screening and global strategy for prostate cancer. Cancer. 75:1995;1187-1189.
2. Narayan P, Tewari A, Konety BV Prostate Cancer. Part I Diagnosis and staging. Hospital Physician. 32:1996;10-34.
3. Bercettoni BA, Carter JR Current concepts review mechanisms of cancer metastasis to bone. J Bone Joint Surg Am. 68:1986;308-312.
4. Jacobs SC Spread of prostatic cancer to bone. Urology. 21:1983;337-344.
5. Papac RJ Bone marrow metastases. Cancer. 74:1994;2403-2413.
6. Wood PW, Banks ER, Humphreys S, McRoberts JW, Rangnekar VM Identification of bone marrow micrometastases in patients with prostate cancer. Cancer. 74:1994;2533-2540.
7. Chackal-Roy M, Niemeyer C, Moore M, Zetter BR Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest. 84:1989;43-50.
8. Ichikawa T, Ichidawa Y, Isaacs JT Genetic factors and metastatic potential of prostatic cancer. Cancer Surv. 11:1991;35-42.
9. Isaacs WB, Bova S, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM Molecular genetics and chromosomal alterations in prostate cancer. Cancer. 75(suppl):1995;2004-2012.
10. Spiers ASD, Deal DR, Kasimis BS, Miller BR Evaluation of the bones and bone marrow in patients with metastatic carcinoma of the prostate. Radiologic, cytologic and cytogenetic findings J Med. 13:1982;303-307.
11. Oshimura M, Sandberg AA Isochromosome 17 in prostatic cancer. J Urol. 114:1975;249-250.
12. Ahmann FR, Woo L, Hendrix M, Trent JM Growth in semisolid agar of prostate cancer cells obtained from bone marrow aspirates. Cancer Res. 46:1986;3560-3564.
13. Sandberg AA (1992): Cytogenetic and molecular genetic aspects of human prostate cancer: primary and metastatic. In: Prostate Cancer and Bone Metastasis. JP Karr, H Yamanaka, eds. Plenum Press, New York, pp. 45-75.
14. Webb HD, Hawkins AL, Griffin CA Cytogenetic abnormalities are frequent in uncultured prostate cancer cells. Cancer Genet Cytogenet. 88:1996;126-132.
15. Gibas Z, Edson Pontes J, Sandberg AA Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet. 16:1985;301-304.
16. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer. 4:1992;16-24.
17. Milaπin J, MiÊiÊ S Double minute chromosomes in an invasive adenocarcinoma of the prostate. Cancer Genet Cytogenet. 75:1994;157-159.
18. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Edson Pontes J Fluorescence in-situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res. 54:1994;3824-3830.
19. Latil A, Baron J-C, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, LeDuc A, Rouegié J, Lidereau R Genetic alterations in localized prostate cancer. Identification of a common region of deletion on chromosome arm 18q Genes Chromosom Cancer. 11:1994;119-125.
20. Visakorpi T, Kallioniemi AH, Syuanen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55:1995;342-347.
21. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Marston Linehan W Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res. 55:1995;2959-2962.
22. Tlaioska JA, Trybus TA, Benson PD, Sakr WA, Grignon DJ, Wojro KD, Pietruk T, Powell IJ Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res. 55:1995;5390-5395.
23. Atkin NB, Baker MC Chromosome study of five cancers of the prostate. Hum Genet. 70:1985;359-364.
24. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB Potential markers of prostate cancer aggressiveness detected by fluorescence in-situ hybridization in needle biopsies. Cancer Res. 54:1994;3574-3579.
25. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kaatendieck H Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet. 66:1993;92-99.
26. Bandyk MG, Zhao L, Tonocoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LWK, Liang JC Trisomy 7. A potential cytogenetic marker of human prostate cancer progression Genes Chromosom Cancer. 9:1994;19-27.
27. Alcaraz AA, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in-situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res. 54:1994;3998-4002.
28. Zitzelsberger H, Szücs S, Weier H-U, Lehmann L, Braselmann H, Enders S, Schilling A, Breul J, Hũffer H, Bauchinger M Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in-situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J Pathol. 172:1994;325-335.
29. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dedden H Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions. Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias Genes Chromosom Cancer. 12:1995;241-250.
30. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res. 55:1995;4114-4119.
31. Kunini K, Bergerheim USR, Larson IL, Ekman P, Peter Collins V Allelotyping of human prostatic adenocarcinoma. Genomics. 11:1991;530-536.
32. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK Loss of chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55:1995;4800-4803.
33. Ittman M Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res. 56:1996;2143-2147.
34. Trybus TM, Burgess AC, Wojno KJ, Glover TW, Macoska JA Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res. 56:1996;2263-2267.
35. 53 gene alterations in human prostate cancer. Cancer Res. 56:1996;3814-3822.
36. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res. 55:1996;1002-1005.